Medications

Added benefit of idelalisib is not proven

Idelalisib (trade name Zydelig) has been available since September 2014 for patients with follicular lymphoma or chronic lymphocytic leukaemia (CLL). The German Institute for Quality and Efficiency in Health Care (IQWiG) ...

Oncology & Cancer

Overweight linked to 500,000 cancer cases per year

Overweight and obesity is now causing nearly half a million new cancer cases in adults every year, roughly 3.6 percent of the world's total, a study said Wednesday.

Medications

Novartis Japan admits concealing drug side effects

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Oncology & Cancer

Cancer uses stem cells as a shield to escape drug attacks

Chemotherapy is one of the most important treatments for all types of cancer. It involves the use of drugs that kill abnormally multiplying cells. The therapy uses one or more drugs in combination and has been practised since ...

page 13 from 18